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Abstract
Intoxication caused by propafenone is very rare, and there are no known detailed epidemiologi-
cal studies. We present the clinical manifestation of severe propafenone intoxication,successfully
treated in a 17 year-old male. He was brought to the Intensive Care Unit after he had taken
3.0 g propafenone. The main clinical findings included: sudden cardiac arrest, coma, hypoten-
sion, left ventricular failure, bradycardia, sinoatrial block, atrioventricular junctional or/and
ventricular tachycardia. During the treatment, transient heart pacing was performed and
catecholamines were administered by means of continuous intravenous infusion of pressure
doses as well as of infusion liquids. Cessation of toxic signs four hours after admission to
hospital was observed. This relatively rare, fully symptomatic intoxication with propafenone
deserved to be presented due to the drug’s common usage in the treatment of dysrhythmia and
life-threatening symptoms of overdosing. The course of the disease was dramatic and the
patient survived only thanks to quick resuscitation, artificial ventilation, transient heart pa-
cing, acidosis treatment and administration of pressure doses of catecholamines. (Cardiol J
2010; 17, 6: 619–622)
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Introduction
Intoxication with pharmaceuticals ingested in
attempted suicides is frequently treated in inten-
sive care units. A significant number of fatal suicides
are related to intoxication with chemical agents and
drugs which are mostly psychoactive. Cases of in-
toxication with propafenone are much rarer. We
present cardiological complications in a 17 year-old
male who ingested 3.0 g of propafenone in a suicide
attempt.
Case report
A 17 year-old male, a student at a secondary
comprehensive school, was brought to the Inten-
sive Care Unit of a regional hospital in the second
hour after a sudden circulatory arrest due to car-
diac asystole. He had taken 10 tablets of propafenone
(Rythmonorm 300 mg) in a suicide attempt; how-
ever this information was disclosed only on the third
day of treatment. Before admission to hospital, the
patient felt acute abdominal pain and then experi-
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enced a short loss of consciousness at home and
then again, due to the sudden circulatory arrest, at
the hospital’s reception room. After a 30-minute
resuscitation, the electrical and hemodynamic ac-
tion of the heart was restored. On arrival at the In-
tensive Care Unit, the patient was in a critical con-
dition.  He was unconscious, respiratorily insuffi-
cient, intubated and artificially ventilated. Wide and
symmetrical pupils reacted poorly to light. Thready
pulse was detected in carotid and femoral arteries.
There were no traumatic changes in the head. Cy-
anosis of the distal parts of limbs was present. The
patient presented severe hypotonia, the arterial
blood pressure was 70/30 mm Hg. The heart rate
was 40 bpm and quiet cardiac sounds were heard.
Electrocardiography examination (ECG) detected
sinus bradycardia with first-degree atrioventricu-
lar block (PQ 280 ms), periodically with sinoatrial
block 2:1 or sinus node suppression with atrioven-
tricular junctional rhythm of a rate 43 bpm and QRS
complexes 200–220 ms (Fig. 1). Intermittent iso-
rhythmic dissociation with junctional rhythm slight-
ly faster than sinus rhythm 42–43 bpm was ob-
served. In the following minutes, a tachycardia of
80–85 bpm appeared, with greatly widened QRS
complexes of 400 ms (Fig. 2), which could be inter-
Figure 2. Wide QRS complex (400 ms) tachycardia 83 bpm: ventricular tachycardia or junctional tachycardia with
aberrant intraventricular conduction.
Figure 1. Sinus bradycardia (PQ 280–360 ms, QRS complexes 200–220 ms), transient sinus arrest or atrioventricular
block 2:1. Atrioventricular junctional rhythm 43 bpm. Periodic isorhythmic dissociation.
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preted as atrioventricular junctional tachycardia
with aberrant intraventricular conduction or ven-
tricular tachycardia. Echocardiography examination
performed at bedside showed severe hypokinesis
and significantly lowered ejection fraction of 20%.
Temporary heart pacing (70 bpm) was introduced.
Medical treatment consisted of 10 mg adrenaline
given in boluses and prolonged infusion, dopamine
and dobutamine, 3 mg of glucagon, natrium bicar-
bonate as well as intravenous fluids. After four
hours following the administration of catechola-
mines (dopamine and dobutamine) and heart stim-
ulation the contractility improved and ejection frac-
tion increased to 45% in a repeated echocardio-
graphy examination. Laboratory examinations
showed transient and slight elevation in activity of
transaminases (alanine transaminase 61 U/L and
aspartate transaminase 69 U/L) and leucocytosis
(11.2 G/L). Blood and urine samples were drawn for
toxicological examination. There was no presence
of drugs in the urine (opiates, amphetamine, cocaine
and marihuana), while barbiturates and benzodiaz-
epines had reached the level above threshold va-
lue (barely perceptible). There were no b-blockers
in the blood serum. No chromatographic semiquan-
titative analysis of urine samples for the presence
of propafenone metabolites was performed, as there
was no information from the patient’s family about
any possibility of the boy taking this drug. During
the following days of treatment, the patient’s con-
dition gradually improved: arterial blood pressure
became stabilized and the diuresis was normal. The
normal sinus rhythm reappeared during the second
day of hospital treatment, and on the following day
the patient regained consciousness and breathing.
On the third day, the patient was separated from
the respirator and extubated. The breathing was
efficient, the patient gained full mental perceptive-
ness, and he admitted to an overdose of 10 tablets
of propafenone (Rythmonorm 300 mg). Echocardio-
graphy showed normal myocardial contractility and
ejection fraction was 65%. A 24-hour Holter ECG
detected sinus rhythm of average frequency of
68 bpm with no dysrhythmia or conduction distur-
bances. Psychiatric examination showed neither
psychotic disorders nor symptoms of depression.
The patient did not have any suicidal thoughts and
regarded his attempt as something negative. Adap-
tation disorders were detected. The patient was dis-
charged in a good condition with the recommenda-
tion to continue outpatient treatment in a mental
health clinic.
Discussion
Although propafenone is a very frequently used
antidysrhythmic drug, intoxications caused by it are
very rare and detailed epidemiological studies are
not known.
Propafenone is a Vaughan Williams Class Ic
antidysrhythmic agent. Propafenone has weak
b-blocking effects (structure similar to that of propra-
nolol), and blocks sodium channel both in the acti-
vated and inactivated state. It is totally absorbed but
its bioavailability is unpredictable because of high
first-pass hepatic elimination. It is metabolized into
two major metabolites, 5-hydroxypropafenone (ac-
tive) and norpropafenone. The metabolism of pro-
pafenone is genetically determined using the CYP
2D6 enzyme system. People lacking the required
enzyme present markedly higher concentrations of
propafenone, even at low doses. Poor metabolizers
are much more susceptible to therapeutic and tox-
ic effects of the drug. The half-time of the parent
compound ranges from two to 12 hours, with a mean
of six hours, and with a 10–12-hour range in poor
metabolizers [1]. Propafenone prolongs refractori-
ness and slow sinoatrial node frequency, conduc-
tion in the atria and in the atrioventricular node.
Because of its type Ic effects, it can aggravate His-
Purkinje block. It is effective in treating supraven-
tricular tachycardia and paroxysmal atrial fibrillation
[1]. Propafenone has a negative inotropic effect, at
least partially due to its beta-adrenergic and calci-
um channel blocking activity [1]. An overdose of
propafenone causes: hypotonia, sleepiness, con-
vulsions, PQ interval prolongation, conduction dis-
order, life-threatening dysrhythmia, ventricular ta-
chycardia as well as ventricular flutter and fibril-
lation and cardiac arrest. Cardiovascular disorders
in acute overdosing of propafenone constitute one
of the major causes of dramatic disease and fatali-
ty [2]. Sudden circulatory arrest due to acute in-
toxication may occur in the mechanisms of asys-
tole, ventricular fibrillation and electromechanical
dissociation of the heart. Hemodynamic disorders
may constitute both the cause and the outcome of
dysrhythmia.
The toxic effects of overdosing propafenone
have rarely been described in the literature [3–6].
Our case is worth paying attention to for several
reasons. First of all, on the first day the patient’s
family failed to inform the hospital of the intoxica-
tion and therefore no lavage of the stomach was
performed. The course of the disease was drama-
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tic and the patient survived only thanks to quick re-
suscitation, artificial ventilation, transient heart pac-
ing, acidosis treatment and administration of intra-
venous catecholamines. There is no efficient way
of eliminating propafenone when overdosed apart
from quickly performed lavage of the stomach [2].
A temporary pacing may prove inefficient in the
case of severe electrical and mechanical heart de-
pression. The reason for no response to the heart
stimulation may be hyperkaliemia, hypoxia and ac-
idosis. Typically, in such a situation, intra-aortic
counterpulsation should be implemented in order
to maintain proper circulation. In the case of our
patient, there was no need for such a treatment and
there was a significant improvement following tem-
porary pacing and the infusion of adrenaline and
catecholamines. Circulatory insufficiency together
with decreased peripheral resistance requires the
administration of both inotropic positive and vaso-
constrictive drugs (dopamine, dobutamine and no-
radrenaline) with intravenous administration of liq-
uids. The case of our patient points to the fact that
even in the case of a structurally healthy heart,
a dose of 3 g of propafenone may be lethal. The great
dynamics of electrical and hemodynamic changes
require prompt action. In the first hours of treat-
ment, our patient suffered from sinus bradycardia,
sinus arrest, sinoatrial and atrioventricular block,
junctional or ventricular tachycardia and signifi-
cant disorders of intraventricular conduction (QRS
4000 ms). It was impossible, due to intubation and
the very serious condition of the patient, to perform
electrocardiography from the esophageal elec-
trodes. For this reason, it was difficult to recognize
origin of dysrhythmia strictly. The disorders, to-
gether with the ejection fraction reduced to 20%,
caused a dramatic decrease in cardiac output, and se-
vere hypotonia including circulatory arrest.
Conclusions
This is a case report of prolonged resuscitation
following propafenone overdose resulting in a good
outcome as a result of timely and aggressive sup-
portive care.
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